Scarica l'app Stockscreener
0.4939
0.92%
-0.0046
Dopo l'orario di chiusura:
.49
-0.0039
-0.79%
Renovaro Inc Borsa (RENB) Ultime notizie
Renovaro: Fiscal Q1 Earnings Snapshot - New Haven Register
Renovaro Inc. (RENB) Quarterly 10-Q Report - Quartzy
Renovaro Inc. revises CFO compensation package - Investing.com India
Renovaro Biosciences Appoints Simon Tarsh as Interim CFO - TipRanks
Renovaro Inc. revises CFO compensation package By Investing.com - Investing.com UK
Renovaro appoints new CEO to advance cancer tech By Investing.com - Investing.com Canada
Renovaro BioSciences issues shareholder letter - TipRanks
Renovaro appoints new CEO to advance cancer tech - Investing.com
Renovaro Issues Shareholder Letter and Provides Corporate Update - GlobeNewswire
Renovaro (NASDAQ:RENB) Trading Down 4%Should You Sell? - MarketBeat
Renovaro's William Anderson Wittekind sells shares worth $1,448 By Investing.com - Investing.com South Africa
Renovaro's William Anderson Wittekind sells shares worth $1,448 - Investing.com India
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing - GlobeNewswire
Renovaro Inc. reshuffles board, appoints new CEO - Investing.com India
Renovaro Inc appoints new CEO, revamps board - Investing.com
Powerful Leadership Transition to Optimize Highly Promising AI - openPR
Renovaro BioSciences announces strategic restructuring, leadership transition - TipRanks
Renovaro Inc. reshuffles board, appoints new CEO By Investing.com - Investing.com UK
Renovaro Names Weinstein as CEO; Four New Board Appointments - MarketWatch
Renovaro Inc appoints new CEO, revamps board By Investing.com - Investing.com UK
Renovaro Announces Strategic Restructuring and Leadership Transition - ForexTV.com
Renovaro Biosciences Appoints New CEO and Board Members - TipRanks
Renovaro Inc. (RENB)’s stock rises to 0.71 per share - US Post News
A Guide To The Risks Of Investing In Renovaro Inc. (RENB) - Knox Daily
Renovaro Inc. (RENB) Stock: A Year of Market Fluctuations - The InvestChronicle
DanDrit Biotech stock hits 52-week low at $0.41 - Investing.com
DanDrit Biotech stock hits 52-week low at $0.41 By Investing.com - Investing.com South Africa
Upward Trajectory: Renovaro Inc. (RENB) Posts a Slidee, Closing at 0.49 - The Dwinnex
Renovaro Inc. (RENB) can make a big difference with a little luck - SETE News
How does RENB’s price to cash per share ratio compare in the market? - US Post News
RENB’s 52-Week Rollercoaster: From $0.42 to $5.25 – What’s Next for Investors? - The InvestChronicle
Renovaro Biosciences soars after responding to Hindenburg short call - MSN
Another «earthquake« in MotoGP? Alberto Puig could be leaving Honda... to be replaced by Francesco Guidotti - Motorcycle Sports
Grab appoints Ronald Roda as Grab Philippines country head - Malaya
Grab PH appoints new country head - The Manila Times
Grab names new Philippines country head - Philstar.com
Grab names Roda as PH country head - manilastandard.net
Grab PH names new country head - pna.gov.ph
Ronald Roda is Grab PH’s new country head as Grace Vera Cruz moves to regional role - MARKETECH APAC
Ronald Roda set to drive growth at Grab Philippines as new Country Head - Bilyonaryo Business News
Grab Philippines announces new country head - GMA News Online
Ronald Roda steps in as new Grab Philippines country head - Backend News
Ensign Peak Advisors Inc Trims Holdings in Graco Inc. (NYSE:GGG) - Defense World
Honda Donates Life-Saving Generators to Power Communities - LionhearTV
MotoGP, the end of an era at Honda: Alberto Puig on the way out and Guidotti's break with KTM approaching - Paddock GP
Renz Fernandez, Jef Gaitan welcome first child - Inquirer.net
Elo Mutual Pension Insurance Co Lowers Holdings in Graco Inc. (NYSE:GGG) - Defense World
Public Employees Retirement Association of Colorado Sells 58,519 Shares of Graco Inc. (NYSE:GGG) - MarketBeat
Federated Hermes Inc. Trims Stock Holdings in Graco Inc. (NYSE:GGG) - Defense World
Analyzing Ratios: Renovaro Inc. (RENB)’s Financial Story Unveiled - The Dwinnex
Renovos Biologics Appoints New Non-Executive Director - European Pharmaceutical Manufacturer
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):